Cargando…
Ubiquitin Conjugating Enzyme E2 H (UBE2H) Is Linked to Poor Outcomes and Metastasis in Lung Adenocarcinoma
SIMPLE SUMMARY: The development of novel treatments for metastatic lung adenocarcinoma is an important issue because some patients do not respond to current standard therapies. Our study aimed to investigate the gene expression profiles in non-tumor tissue, primary tumor tissue, and the metastatic l...
Autores principales: | Yen, Meng-Chi, Wu, Kuan-Li, Liu, Yu-Wei, Chang, Yung-Yun, Chang, Chao-Yuan, Hung, Jen-Yu, Tsai, Ying-Ming, Hsu, Ya-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146699/ https://www.ncbi.nlm.nih.gov/pubmed/33924823 http://dx.doi.org/10.3390/biology10050378 |
Ejemplares similares
-
Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression
por: Ren, Xiaoyue, et al.
Publicado: (2021) -
Ubiquitin-Conjugating Enzyme UBE2C Is Highly Expressed in Breast Microcalcification Lesions
por: Chou, Chen-Pin, et al.
Publicado: (2014) -
Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer
por: Kariri, Yousif, et al.
Publicado: (2022) -
Conformational Dynamics Modulate Activation of the
Ubiquitin Conjugating Enzyme Ube2g2
por: Magala, Pearl, et al.
Publicado: (2017) -
Predictive Potential of Circulating Ube2h mRNA as an E2 Ubiquitin-Conjugating Enzyme for Diagnosis or Treatment of Alzheimer’s Disease
por: Lim, Key-Hwan, et al.
Publicado: (2020)